Research Project
Grant-in-Aid for Young Scientists (B)
Malignant pleural mesothelioma (MPM) is an aggressive malignancy. Therefore, novel therapeutic strategies for MPM are urgently necessary for improving the prognosis. In this study, I investigated whether anti-HM1.24 antibody can induce antitumor effects against MPM. Immunostaining showed the expression of HM1.24 of MPM cell lines and malignant mesothelioma tissues. Furthermore, anti-HM1.24 antibody could induce potent ADCC and CDC against HM1.24-positive MPM cells. These results strongly suggest that targeting therapy with therapeutic antibodies might be useful as a novel immunotherapy against MPM.
All 2013 2012 2011
All Journal Article (2 results) (of which Peer Reviewed: 2 results) Presentation (16 results)
J Immunol
Volume: 190 Issue: 12 Pages: 6239-6249
10.4049/jimmunol.1300448
The Journal of Immunology
Volume: 未定